Josh Hawley seeks DOJ abortion drug investigation amid FDA safety review

Published April 14, 2026 6:47pm ET | Updated April 15, 2026 11:14am ET



President Donald Trump’s Justice Department is facing mounting pressure from Republican and conservative advocates to investigate Danco Laboratories, the primary distributor of the abortion drug mifepristone, as scrutiny intensifies over the drug’s safety and regulatory oversight.

Sen. Josh Hawley (R-MO) is leading that effort, penning a letter Tuesday to acting Attorney General Todd Blanche asking him to open a sweeping investigation into the company’s business practices, approval process, and compliance with federal law.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.